首页> 外文OA文献 >GW26-e1352 Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Meta-Analysis of Randomized Controlled Trials

【2h】

GW26-e1352 Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Meta-Analysis of Randomized Controlled Trials

机译：GW26-e1352比伐卢定与肝素加糖蛋白IIb / IIIa抑制剂在经皮冠状动脉介入治疗的急性冠脉综合征患者中的作用：一项随机对照试验的荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
ZHU Jianbing; Ge Junbo;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials (vol 15, pg 275, 2015) [J] . Ibebuogu Uzoma N., Bolorunduro Oluwaseyi, Giri Smith, American journal of cardiovascular drugs: drugs, devices, and other interventions . 2015,第4期

机译：比伐卢定与肝素加糖蛋白IIb / IIIa抑制剂在接受经皮冠状动脉介入治疗的糖尿病患者中的作用：一项随机对照试验的荟萃分析（第15卷，第275页，2015年）
2. Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials [J] . Ibebuogu Uzoma N., Bolorunduro Oluwaseyi, Giri Smith, American journal of cardiovascular drugs: drugs, devices, and other interventions . 2015,第4期

机译：比伐卢定对肝素加糖蛋白IIb / IIIa抑制剂在接受经皮冠状动脉介入治疗的糖尿病患者中的作用：一项随机对照试验的荟萃分析
3. Meta-analysis of randomized clinical trials comparing Bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention and in patients with ST-segment elevation myocardial infarction [J] . NairoozR., SardarP., AminH., The American Journal of Cardiology . 2014,第2期

机译：比较比伐卢定与肝素加糖蛋白IIb / IIIa抑制剂在经皮冠状动脉介入治疗患者和ST段抬高型心肌梗死患者中的随机临床试验的荟萃分析
4. The Long-Term Clinical Outcomes of Platelet Glycoprotein Ilb/IIIa Inhibitor Combined with Low Molecular Weight Heparin in Patients with Acute Coronary Syndrome [C] . J.H. Kim, M.H. Jeong, Y.J. Hong, International Congress on Thrombosis . 2004

机译：血小板糖蛋白ILB / IIIa抑制剂的长期临床结果与急性冠状动脉综合征患者低分子量肝素联合
5. The Association between Unfractionated Heparin and Bivalirudin Used during Percutaneous Coronary Intervention for Stable Angina and Acute Coronary Syndromes and the In-Hospital and Mortality Outcomes Observed across All Body Mass Index Groups [D] . Chen, Christine. 2021

机译：在所有体重指数群体中观察到稳定冠状动脉干预期间使用经皮冠状动脉介入和急性冠状动脉综合征的冠状动脉介入和医院和死亡率结果之间的联合肝素和Bivalirudin之间的关联
6. Bivalirudin versus Heparin plus Glycoprotein IIb/IIIa Inhibitors in Women Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials [O] . Haiyan Xu, Bingjian Wang, Jing Yang, -1

机译：比伐卢定vs肝素加糖蛋白IIb / IIIa抑制剂在接受经皮冠状动脉介入治疗的妇女中：一项荟萃分析的随机对照试验。
7. Erratum to: Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials [O] . Uzoma N. Ibebuogu, Oluwaseyi Bolorunduro, Smith Giri, 2015

机译：错误至：Bivalirudin与肝素加上糖蛋白IIB / IIIA抑制剂在经皮冠状动脉介入的糖尿病患者中：随机对照试验的荟萃分析

GW26-e1352 Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Meta-Analysis of Randomized Controlled Trials

著录项

引文网络

相似文献

相关主题

期刊订阅